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Abstract
Ossification disturbance in femoral head reportedly is seen in the Spontaneously Hyperten-
sive rats (SHR) between ages of 10 and 20 weeks. We investigated serum and tissue levels of
insulin-like growth factor-1 (IGF-1) and vascular endothelial growth factor (VEGF) in SHR rele-
vant to the ossification disturbance and osteonecrosis of the femoral head. Serum levels of IGF-1
and VEGF were significantly lower in SHR than in Wistar Kyoto rats (WKY) at weeks 5, 10, 15
and 20 (p<0.005). The incidence of histological ossification disturbance of the femoral head was
higher in SHR (59%) than in WKY (40%) at week 20. Lower serum and local levels of VEGF
in SHR appeared to be related to the incomplete ossification of the femoral heads. Immunohisto-
chemical study showed significantly lower numbers of IGF-1 and VEGF positive chondrocytes in
the femoral epiphyseal cartilage of SHR than in those of WKY at weeks 10, 15 and 20. Our re-
sults suggest that local and/or systemic levels of IGF-1 and VEGF between ages of 5 and 20 weeks
might play roles in the pathogenesis of ossifi cation disturbance of the femoral head in SHR.
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egg-Calve-Perthes’disease (LCPD) is charac-
terized by ossiﬁ cation disturbance and subse-
quent osteonecrosis of the femoral head.  The 
reported incidence of LCPD is approximately 
1 : 9,000 children (1 : 8,000 boys and 1 : 30,000 girls) 
and 80ｵ of the cases are found between the ages of 
4 and 9 years [1ﾝ6].  If LCPD is untreated or not 
treated appropriately,  ossiﬁ cation disturbance devel-
ops ﬂ attening of the femoral head due to osteonecro-
sis,  which can leave a deformity that result in osteo-
arthritis of the hip in adult life.  Although the 
prognosis is clear,  the pathogenesis of LCPD is still 
uncertain.
　　The spontaneously hypertensive rats (SHR) is 
widely used as an animal model for hypertension. 
SHR exhibit a variety of hormonal imbalances, 
including prolactin,  follicle-stimulating hormone,  tes-
tosterone [7-9],  and parathyroid hormone [10], 
which are known to inﬂ uence the process of chondro-
genesis and bone remodeling.  It is also known that 
the SHR exhibits osteonecrosis of the femoral head 
between the ages of 10 and 20 weeks,  the period 
Decreased Levels of Insulin-like Growth Factor-1 and
Vascular Endothelial Growth Factor Relevant
to the Ossiﬁ cation Disturbance in Femoral Heads
Spontaneous Hypertensive Rats
Takamitsu Komiyamaa,  Keiichiro Nishidaa,b＊,  Masanori Yorimitsua,
Hideyuki Doia,  Shinichi Miyazawaa,  Ai Kitamuraa,  Aki Yoshidaa,  Yoshihisa Nasua,
Nobuhiro Abea,  and Toshifumi Ozakia
Departments of aOrthopaedic Surgery,  and bHuman Morphology,  Okayama University Graduate School of Medicine,
Dentistry and Pharmaceutical Sciences,  Okayama 700 ﾝ8558,  Japan
L
Ossiﬁ cation disturbance in femoral head reportedly is seen in the Spontaneously Hypertensive rats 
(SHR) between ages of 10 and 20 weeks.  We investigated serum and tissue levels of insulin-like 
growth factor-1 (IGF-1) and vascular endothelial growth factor (VEGF) in SHR relevant to the ossiﬁ -
cation disturbance and osteonecrosis of the femoral head.  Serum levels of IGF-1 and VEGF were sig-
niﬁ cantly lower in SHR than in Wistar Kyoto rats (WKY) at weeks 5,  10,  15 and 20 (p ＜ 0.005).  The 
incidence of histological ossiﬁ cation disturbance of the femoral head was higher in SHR (59ｵ) than in 
WKY (40ｵ) at week 20.  Lower serum and local levels of VEGF in SHR appeared to be related to the 
incomplete ossiﬁ cation of the femoral heads.  Immunohistochemical study showed signiﬁ cantly lower 
numbers of IGF-1 and VEGF positive chondrocytes in the femoral epiphyseal cartilage of SHR than 
in those of WKY at weeks 10,  15 and 20.  Our results suggest that local and/or systemic levels of 
IGF-1 and VEGF between ages of 5 and 20 weeks might play roles in the pathogenesis of ossiﬁ cation 
disturbance of the femoral head in SHR.
Key words : spontaneous hypertensive rats,  insulin like growth factor-1,  vascular endothelial growth factor, 
ossiﬁ cation disturbance,  osteonecrosis
Acta Med.  Okayama,  2006
Vol.  60,  No.  3,  pp.  141ﾝ148
http ://www.lib.okayama-u.ac.jp/www/acta/
CopyrightⒸ 2006 by Okayama University Medical School.
Original Article
Received August 9, 2005 ; accepted November 30, 2005.
 ＊Corresponding author. Phone : ＋81ﾝ86ﾝ235ﾝ7273 ; Fax : ＋81ﾝ86ﾝ223ﾝ9727
E-mail : knishida@md.okayama-u.ac.jp (K. Nishida)
1
Komiyama et al.: Decreased levels of insulin-like growth factor-1 and vascular
Produced by The Berkeley Electronic Press, 2006
preceding skeletal maturity.  Although the mechanism 
of osteonecrosis seen in SHR remains unclear,  SHR 
is accepted for the animal model of human LCPD 
because radiographic appearances of the femoral 
heads of SHR resemble those of LCPD [11-13]. 
Recent radiographic and histological analyses demon-
strated that the osteonecrosis in SHR is preceded by 
a disturbance of the cartilage mineralization and 
ossiﬁ cation,  despite normal hypertrophy of the 
epiphyseal cartilage,  suggesting that abnormal devel-
opment of the femoral epiphysis occurs much earlier 
than the osteonecrosis [14-16].  Recent report sug-
gested that the occlusion of the epiphyseal vessels 
during the process of enchondral ossiﬁ cation might 
induce the ischemic necrosis of the femoral head, 
which might lead to the breakdown of the vulnerable 
immature epiphysis in SHR by the mechanical forces 
[16].
　　Two of the known factors required for enchondral 
ossiﬁ cation are insulin-like growth factor (IGF-1) and 
vascular endothelial growth factor (VEGF).  IGF-1 is 
an essential factor for cell function and diﬀ erentia-
tion of chondrocytes during enchondral ossiﬁ cation 
[17]. Neidel et al.  reported persistent,  low serum 
levels of IGF-1 in prepubertal children with LCPD 
[18].  More recently,  Kikkawa et al.  reported that 
peak expression of IGF-1 in epiphyseal chondrocytes 
in SHR is delayed when compared with Wistar Kyoto 
rats (WKY) during the ages of 1 to 6 weeks [14]. 
Although the precise relationship is unclear in chon-
drocytes,  IGF-1 is known to regulate production of 
VEGF in other cell types [8,  19-22].  VEGF is 
responsible for hypertrophic cartilage neovascular-
ization through a paracrine release by chondrocyres, 
and promotes the invasion of endothelial cells into 
the cartilaginous tissue [23].  In the current study, 
we used SHR,  and the closely related WKY,  which 
do not develop spontaneous osteonecrosis of the fem-
oral head.  We hypothesized that if the inhibition of 
vascular invasion into the epiphyseal cartilage and 
ossiﬁ cation disturbance of the SHR femoral head are 
related to the low serum or low tissue levels of 
IGF-1 and VEGF,  then the levels of both factors 
should be diﬀ erent in the 2 types of rats during the 
developmental period preceding skeletal maturity.
Materials and Methods
　　Animals.　 SHR were originally raised by 
selective inbreeding of WKY.  We used SHR (n＝40) 
(Charles River Inc.,  Yokohama,  Japan) as the dis-
ease models of epiphyseal ossiﬁ cation disturbance of 
cartilage,  and WKY (n＝20) (Charles River Inc., 
Yokohama,  Japan) as normal control animals.  All 
animals were used in accordance with the Policies 
and Guidelines for Care and Use of Laboratory 
Animals of Okayama University,  and all eﬀ orts were 
made to minimize animal suﬀ ering.  The rats were 
euthanized by systemic perfusion of a mixture of 2ｵ 
paraformaldehyde and 2ｵ glutaraldehyde in 0.1 M 
phosphate-buﬀ ered saline (PBS) under general anes-
thesia at weeks 5,  10,  15 and 20 (SHR : each 10, 
WKY : each 5),  and the serum samples were taken 
and stored at －80 ℃ until analysis.
　　Radiographic study.　 The femoral head sam-
ples were perfusion-ﬁ xed with a mixture of 2ｵ para-
formaldehyde and 2ｵ glutaraldehyde in 0.1 M PBS. 
The radiographs of excised samples were taken by 
Softex CNB-2 (MFG and EXP,  Softex Co.  Ltd., 
Tokyo,  Japan ; 52 kV,  40 mA,  exposure time 10 s). 
All the radiographic analyses were carried out on 
printed pictures magniﬁ ed at×100.  In the current 
study,  the radiographic appearances of the femoral 
heads were divided into 3 types ; Round (no sign of 
deformation or fracture),  Flat (deformation of femo-
ral head without bone fracture),  and Crushed (defor-
mation and bone fracture of femoral head) (Fig.  1).
　　Measurement of IGF-1 and VEGF concen-
trations in the serum samples.　 Serum samples 
were taken from both WKY and SHR at weeks 5, 
10,  15 and 20.  The concentration of VEGF was 
measured by ELISA (Quantikine Mouse VEGF 
ELISA Kit,  R&D systems Inc.,  Minneapolis,  MN, 
USA),  and IGF-1 by radioimmunoassay (Rat IGF-1 
Radioimmunoassay Kit,  Diagnostic Systems 
Laboratories Inc.,  Webster,  TX,  USA).  The serum 
levels of IGF-1 and VEGF in SHR at each stage 
were analyzed separately to further examine the dif-
ference between histological stages,  and the correla-
tion with ossiﬁ cation of the femoral heads.
　　Histological examination.　 Samples were 
decalciﬁ ed in 4ｵ ethylene diamine tetra-acetic acid 
(EDTA) and 10ｵ sucrose in cacodylate buﬀ er (pH 
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7.3) for 7ﾝ10 days.  The coronal araﬃ  n sections 
(4.5 μm) were stained by hematoxylin and eosin. 
Histological appearances of the femoral heads were 
scored from 0 to 2,  according to the area of ossiﬁ ca-
tion ; Stage 0 : ossiﬁ cation of less than 1/3 of the 
femoral head,  Stage 1 : ossiﬁ cation from 1/3 to 2/3 
of the femoral head,  Stage 2 : ossiﬁ cation of 2/3 or 
more of the femoral head (Fig.  2).  Blinded assess-
ments of histological and radiographic data were 
made independently by 2 of the authors (TK and KN). 
Diﬀ erences in opinions were resolved by consensus. 
　　Immunohistochemistry.　 The paraﬃ  n sec-
tions were incubated with 0.3ｵ H₂O₂ that diluted 
with PBS for 30 min at room temperature to inacti-
vate endogenous peroxidase.  Each section was 
treated with PBS containing 2ｵ BSA for 30 min at 
room temperature to block non-speciﬁ c binding to 
sections and eliminate non-speciﬁ c staining.  The 
slides were then incubated with rabbit polyclonal 
anti-IGF-1 (5 μg/ml) or goat polyclonal anti-VEGF 
(5 μg/ml) (Santa Cruz Biotechnology,  Santa Cruz, 
CA,  USA) at 4 ℃ overnight,  and incubated for 
30 min at room temperature with the secondary anti-
body (DAKO LSAB Kit,  DAKO,  Kyoto,  Japan). 
After 3 washings by PBS,  the sections were 
immersed in 0.1ｵ 3,3’-diaminobenzidine tetrahydro-
chloride (DAB) and 1ｵ hydrogen peroxide.  The sec-
tions were then counterstained with methylgreen, 
and observed by light microscopy.
　　Quantitative analysis for IGF-1 and VEGF 
positive cells.　 The population of IGF-1 and 
VEGF positive chondrocytes within the femoral 
heads was examined in SHR (n＝10) and WKY (n＝5) 
at weeks 10,  15 and 20.  The positive-cell numbers 
were counted within the 3 deﬁ ned square areas 
(medial,  central,  lateral,  20 × 20 μm) of Stage 0 
and 1 femoral epiphyseal cartilage of the rats at 
weeks 10,  15 (SHR ; n＝10,  WKY ; n＝10) and 20 
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Round Flat Crushed
Fig. 1　　Radiographic appearances of the femoral heads of SHR (Softex).  Femoral heads were divided into 3 types : Round,  Flat, 
Crushed.
Stage 0 Stage 1 Stage 2
Fig. 2　　Histology of the epiphysis of femoral head of SHR (HE stain).  Femoral heads were classiﬁ ed into the following 3 stages 
according to the pathological ﬁ ndings.  Stage 0,  ossiﬁ cation less than 1/3 of femoral head ; Stage 1,  ossiﬁ cation from 1/3 to 2/3 of the 
femoral head ; Stage 2,  ossiﬁ cation more 2/3 of the femoral head (original magniﬁ cation×10).
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(SHR ; n＝10,  WKY ; n＝4),  and averaged.  There 
was no diﬀ erence in ossiﬁ cation pattern in the femo-
ral heads between SHR and WKY at week 5.
　　Statistical analysis.　 The serum levels of 
IGF-1 and VEGF were expressed as mean＋/－SD. 
Diﬀ erences between WKY and SHR were statisti-
cally analyzed by Mann-Whiteney U test or by 
Student’s t-test appropriately using Macintosh Stat-
View version 6 (SAS Institute Inc.,  Cary,  NC, 
USA).
Results
　　Radiological study.　 The radiographic 
morphology of the femoral heads of WKY was Round 
throughout the study,  except for one femoral head 
(10ｵ) at week 20,  which showed a Flat appearance. 
In contrast,  Flat femoral heads were seen in 40ｵ 
and in 60ｵ of SHR at weeks 10 and 15, 
respectively.  Femoral heads with a Crushed 
appearance were seen in 5ｵ and in 15ｵ of SHR at 
weeks 15 and 20,  respectively (Table 1).
　　Serum levels of IGF-1 and VEGF.　 Serum 
levels of IGF-1 were signiﬁ cantly lower in SHR than 
in WKY at weeks 5,  10 and 15.  There was no 
signiﬁ cant diﬀ erence in serum levels of IGF-1 
between 2 lines of rats at week 20.  The serum levels 
of VEGF were signiﬁ cantly lower in SHR than in 
WKY at each measurement point (p＜0.005) (Table 
2).  Analysis by ELISA showed the serum levels of 
IGF-1 were not signiﬁ cantly diﬀ erent among the 
stages at weeks 10 and 20.  Although the serum 
levels of IGF-1 associated with Stage 1 and 2 
cartilage were signiﬁ cantly lower than those of Stage 
0 in SHR at week 15 (p＜0.01,  p＜0.05,  respectively) 
(Fig.  3),  the levels were much lower than those with 
WKY at the same age.  The serum levels of VEGF 
were not signiﬁ cantly diﬀ erent among the stages in 
SHR at week 10.  However,  at week 15,  the serum 
levels of VEGF in SHR with Stage 0 and 1 femoral 
heads were signiﬁ cantly lower than those with Stage 
2 (p＜0.05 and p＜0.005,  respectively).  At week 20, 
the serum levels of VEGF of Stage 0 were 
signiﬁ cantly lower than those of Stages 1 and 2 in 
SHR (p＜0.005) (Fig.  3).
　　Histology.　 The number of femoral heads in 
each stage of ossiﬁ cation was summarized in Table 3. 
The femoral heads of SHR at week 5 and WKY at 
weeks 5,  10 and 15 showed no ossiﬁ cation (Stage 0). 
At week 10,  Stage 0 ossiﬁ cation was seen in 8 of 20 
femoral heads (40ｵ),  and Stage 1 ossiﬁ cation was 
seen in 4 of 20 femoral heads (20ｵ) of SHR.  Two of 
the latter had osteonecrosis with empty lacunae. 
Stage 2 ossiﬁ cation was seen in 8 of 20 femoral 
heads (40ｵ) of SHR,  2 of which had osteonecrosis. 
At week 15,  all 3 stages of ossiﬁ cation of the 
femoral head were seen : Stage 0 in 4 (21.1ｵ), 
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Table 1　　Number of femoral heads in each radiographic type
10 weeks 15 weeks 20 weeks
SHR WKY SHE WKY SHR WKY
Round 12 10 7 10 7 9
Flat 8 0 12 0 10 1
Crushed 0 0 1 0 3 0
Total 20 10 20 10 20 10
Table 2　　Serum levels of IGF-1 and VEGF
　IGF-1 (ng/ml)
5 weeks 10 weeks 15 weeks 20 weeks
SHR (n=40) 633.8± 86.2 1082.9±152.3 1115.0±154.0 988.9±106.9
WKY (n=20) 1156.4±127.9* 1586.0±231.5* 1414.0±227.9* 1164.4±206.5
(*p<0.005)
　VEGF (pg/ml)
5 weeks 10 weeks 15 weeks 20 weeks
SHR (n=40) 61.7±30.6 58.2±2.5 58.9±4.5 59.2±3.8
WKY (n=20) 67.1± 6.1* 71.9±5.3* 72.7±4.4* 73.4±5.6*
(*p<0.005)
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Stage 1 in 6 (31.6ｵ),  and Stage 2 in 9 (47.4ｵ) of 
19 SHR femoral heads.  Seven of 9 Stage 2 SHR 
femoral heads (77.8ｵ) showed osteonecrosis.  At 
week 20,  the incidence of Stage 1 and 2 ossiﬁ cation 
of the WKY femoraldeads (10 of 10,  100ｵ) was 
higher than those in SHR (13 of 17 heads ; 76.4ｵ) 
and 12 of 17 femoral heads (70.6ｵ) of SHR was 
showed osteonecrosis.  Extensive crushing precluded 
further histological analysis of 4 of the SHR femoral 
heads at weeks 15 (1 head) and (3 heads).
　　Immunohistochemistry.　 The local expression 
of IGF-1 showed a signiﬁ cant and transient increase 
at week 15 followed by a decrease at week 20 in 
SHR and WKY.  The populations of IGF-1 positive 
chondrocytes in the femoral heads of WKY were 
50.8±20.5ｵ,  87.5±5.2ｵ,  and 7.0±16.9ｵ at weeks 
10,  15,  and 20,  respectively.  The positive reactions 
for IGF-1 were signiﬁ cantly lower in hypertrophic 
chondrocytes in the femoral heads of SHR at weeks 
10,  15 and 20 (p＜0.001) (Fig.  4).  The populations 
of VEGF positive chondrocytes were signiﬁ cantly 
lower than those in WKY throughout the 
experimental period (Fig.  5).
Discussion
　　The histological analysis of the current study 
showed that osteonecrosis was found in 4 of 20 and 7 
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Fig. 3　　Serum levels of IGF-1 and VEGF in each ossiﬁ cation stage at weeks 10,  15 and 20 in SHR.  At week 15,  serum levels of IGF-1 
of Stage 0 were signiﬁ cantly higher than those of Stages 1 and 2.  Serum levels of IGF-1 were not signiﬁ cantly diﬀ erent among the stage 
at weeks 10 and 20.  Serum levels of VEGF were not signiﬁ cantly diﬀ erent among the stages at week 10.  At week 15,  serum levels of 
VEGF of Stage 2 were signiﬁ cantly higher than those of Stages 0 and 1.  At week 20,  serum levels of VEGF of Stage 0 were signiﬁ cantly 
lower than those of Stages 1 and 2.
Table 3　　Number of femoral heads in each stage of ossiﬁ cation
5 weeks 10 weeks 15 weeks 20 weeks
SHR WKY SHR WKY SHR WKY SHR WKY
Stage 0 20 10  8 10 4 10  4(2) 0
Stage 1 0 0 4(2)  0 6  0  6(5) 4
Stage 2 0 0 8(2)  0 9(7)  0  7(5) 6
Total 20 10 20 10 19 10 17 10
( ) : Osteonecrosis
5
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of 19 SHR femoral heads at weeks 10 and 15, 
respectively despite the higher incidence of ossiﬁ ca-
tion (Stage 1 and 2) in SHR than WKY at the same 
time points.  At week 20,  WKY showed Stage 1 or 2 
ossiﬁ cations in 13 of 17 femoral heads,  however, 
osteonecrosis was seen in only 71.1ｵ (12 of 17) of 
them.  These ﬁ ndings agree with those of Sibahara et 
al. who reported that the ossiﬁ cation disturbance and 
osteonecrosis of femoral heads in SHR are fre-
quently seen between ages of 10 and 20 weeks [16]. 
These results suggested that the period between 
weeks 5 and 20 might be crucial for the investigation 
for the causation of the ossiﬁ cation disturbance, 
incomplete ossiﬁ cation and osteonecrosis seen in 
SHR.
　　Several studies have reported delayed expression 
of the serum levels of IGF-1 during the development 
of SHR [14,  24,  25].  Neidel et al. reported that 
serum levels of IGF-1 were lower in LCPD than in 
the control group,  and this decrease was conﬁ ned to 
the ﬁ rst 2 years of the disease and followed by a non-
signiﬁ cant rebound [18].  Our results of current 
study showed that the serum levels of IGF-1 were 
signiﬁ cantly lower in SHR than in WKY at weeks 5, 
10 and 15,  but not at week 20.  As IGF-1 is known 
to promote the proliferation of osteoblasts,  and stim-
ulates the activation of IGF receptor,  Ras,  ERK1/2 
and Akt in osteoprogenitor cells [26],  low level of 
serum IGF-1 seen in SHR might induce the early 
incomplete ossiﬁ cation.  Immunohistochemical study 
demonstrated that local expression levels of IGF-1 
by chondrocytes of SHR were signiﬁ cantly lower 
than those of WKY.  The increase in the number of 
IGF-1 positive cells at weeks 15 might promote the 
terminal diﬀ erentiation of chondrocytes toward ossi-
ﬁ cation.  The relatively low level of IGF-1 in SHR 
might be insuﬃ  cient to promote chondrocyte diﬀ eren-
tiation,  which could lead to ossiﬁ cation disturbance. 
The serum levels of IGF-1 of SHR did not relate to 
the histological appearance of femoral heads at weeks 
10 and 20.  However,  the levels were signiﬁ cantly 
lower in SHR femoral heads of Stages 1 and 2 at 
146 Acta Med.  Okayama　Vol.  60,  No.  3Komiyama et al.
WKY SHR
100
80
60
40
20
0
Th
e 
ra
tio
 o
f 
IG
F-
1 
po
si
tiv
e 
ce
lls
(ｵ)
IGF-1
WKY SHR
10 w
15 w
20 w
*p<0.001
10 w 15 w 20 w
Fig. 4　　Immunohistochemical staining for IGF-1 on paraﬃ  n embedded hypertrophic chondrocytes in the epiphysis of femoral heads at 
weeks 10,  15 and 20 (original magniﬁ cation 200×).  The number of hypertrophic chondrocytes with positive for IGF-1 tended to increase 
in both groups of rats at weeks 10 and 15.  However at week 20,  the numbers decreased signiﬁ cantly.  The ratio of the positive cells for 
IGF-1 in SHR was signiﬁ cantly lower in WKY at weeks 10,  15 and 20.  The arrow is positive cell for IGF-1.
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week 15 (Fig.  4).  The reason of this transient 
increase of serum IGF-1 is unclear,  but it might 
explain the dissimilar ﬁ ndings in serum levels of 
IGF-1 in LCPD in the previous studies [27,  28].
　　VEGF is expressed by hypertrophic chondrocytes 
and promotes the ossiﬁ cation by angiogenesis [24]. 
In the current study,  serum VEGF level was lower 
in SHR with Stage 0 or 1 femoral heads than those 
with Stage 2 at weeks 15,  and lower in SHR with 
Stage 0 femoral heads than those with Stage 1 or 2 
at weeks 20 (Fig.  4).  These results suggest that low 
level of serum VEGF might be related to the incom-
plete ossiﬁ cation.  Kim et al.  reported that VEGF 
expression was increased in ischemic piglet femoral 
heads,  and its spatial expression was altered in the 
epiphyseal cartilage after ischemic necrosis of the 
immature femoral head [25].
　　Our results suspected that osteonecrosis of incom-
plete ossiﬁ cation femoral head in SHR was lead by 
lower serum and local levels of IGF-1 and VEGF, 
and that a condition of lower serum and local levels 
of IGF-1 and VEGF could not preserve adequate 
bone metabolism in femoral head.  IGF-1 and VEGF 
are known to be essential coordinators of chondro-
cyte diﬀ erentiation and ossiﬁ cation,  chondroclast 
function,  angiogenesis and bone formation in femoral 
heads.  The regulatory mechanism of serum levels of 
IGF-1 and VEGF in SHR is still unknown.  The rela-
tionship between IGF-1 and VEGF has been reported 
with various cells,  in the endothelial cells or carci-
noma cells,  IGF-1 promotes the expression of 
VEGF,  which is an essential growth factor involved 
in neovascularization,  vascular invasion,  and activa-
tion of osteoprogenitor cells [8,  19-21].  In retinal 
cells,  IGF-1 has been shown to act synergistically 
with VEGF to increase angiogenesis [22].  Whilst 
clariﬁ cation of the regulation of IGF-1 and VEGF in 
chondrocytes is needed,  the current study was not 
designed to show causation and did not attempt to 
show the strength of the relationship between IGF-1 
and VEGF.  In the current study,  serum levels of the 
2 factors did not appear to relate to the stages of 
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Fig. 5　　Immunohistochemical staining for VEGF on paraﬃ  n embedded hypertrophic chondrocytes in the epiphysis of femoral heads at 
weeks 10,  15 and 20 (original magniﬁ cation 200×).  The number of hypertrophic chondrocytes positive for VEGF tended to increase in 
both rats at weeks 10,  15 and 20.  The ratio of the positive cells for VEGF in SHR was signiﬁ cantly lower in WKY at weeks 10,  15 and 
20.
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ossiﬁ cation in a consistently parallel manner. 
However,  the results of immunohistochemistry indi-
cated that local expression of IGF-1,  as well as 
VEGF in hypertrophic chondrocytes of SHR femoral 
head were signiﬁ cantly lower than those in WKY 
(Fig.  4,  5).
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